Pre-eclampsia complicates 4.6% of pregnancies and is linked to impaired placentation; likely due to dysregulated vasculogenesis/angiogenesis. Proteoglycans, such as biglycan, are located on the endothelial surface of fetal capillaries. Biglycan is reduced in the placenta of pregnancies complicated by fetal growth restriction and pre-eclampsia. Importantly, biglycan stimulates angiogenesis in numerous tissues. Therefore, this study investigated whether biglycan knockdown in mice results in a pre-eclamptic phenotype. Wild-type (WT) and Bgn-/- mice underwent cardiorenal measurements prior to and during pregnancy. One cohort of mice underwent post-mortem on gestational day 18 (E18) and another cohort underwent post-mortem on postnatal day 1 (PN1), with maternal and offspring tissues of relevance collected. Bgn-/- dams had increased heart rate (+9%, p<0.037) and reduced systolic (-11%, p<0.001), diastolic (-15%, p<0.001), and mean arterial (-12%, p<0.001) pressures at all ages investigated compared to WT. Additionally, Bgn-/- dams had reduced urine flow rate (-64%, p<0.001) as well as reduced urinary excretions (-49%, p<0.004) during late gestation compared to WT. Bgn-/- pups had higher body weight (+8%, p=0.004; E18 only) and a higher liver-to-brain weight ratio (+43%, p<0.001). Placental weight was unaltered with only minor changes in vasculogenic and angiogenic gene abundances detected, which did not correlate to changes in protein expression. This study demonstrated that total knockdown of biglycan is not associated with features of pre-eclampsia.